Share on :

Asset Summary

Daily Performance Report for MRNA ETF: Nov 16, 2024

Summary: The day started with MRNA ETF opening at $37.12 and closing at $37.27. The ETF showed resilience throughout the day, with the highest price observed at $37.27 and the lowest at $37. The underlying asset had a trading range of $0.27 Overall, it was a positive trading day for MRNA ETF, reflecting investor optimism and market activity.

Change in Closing Price: There was a net increase of $0.15 or 0.40% in the closing price from the opening to the closing price over the day.

Volume Analysis: Trading volume for MRNA ETF was 9,536 units during Nov 16, 2024, indicating active market participation and investor interest.

Opening Price: The day started at $37.12.

Highest Price: The highest price observed during the day was $37.27.

Lowest Price: The lowest price observed during the day was $37.

Closing Price: The day ended at $37.27.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Empower Your MRNA Trading Now

Maximize your trading efficiency with RankMyTrade Online. Our advanced trading system provides detailed insights and actionable strategies for MRNA. Don’t wait—Transform your trading strategy now and see how our platform can help you achieve your trading goals!

Start Optimizing Now

Frequently Asked Questions

Moderna has established partnerships with various organizations, including government agencies and pharmaceutical companies, to enhance its research and development capabilities.

The COVID-19 vaccine significantly increased Moderna’s revenue and visibility in the biotechnology sector.

Investors can purchase MRNA stock through a brokerage account, similar to any publicly traded stock.

Yes, Moderna is publicly traded on the NASDAQ under the ticker symbol MRNA.

Innovation is central to Moderna’s mission, as it continuously works on advancing mRNA technology and expanding its applications.

Moderna is exploring therapies for infectious diseases, cancer, and rare diseases, leveraging its mRNA platform.

Moderna is best known for its COVID-19 vaccine, mRNA-1273, as well as several other mRNA-based therapies in development.

Moderna focuses on developing vaccines and treatments for public health challenges, responding to emerging infectious diseases.

Moderna has been actively involved in rapid vaccine development in response to pandemics, including its COVID-19 vaccine.

Moderna conducts extensive preclinical and clinical trials to evaluate the safety and efficacy of its products before they reach the market.

Unlock Your MRNA Trading Now

Empower your trading with Rankmytrade. Our comprehensive platform delivers precise analysis and strategic insights for MRNA, designed to improve your trading outcomes. Enhance your market performance today and unlock new opportunities with our advanced system!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs